1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
By Elana Gotkine HealthDay Reporter
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online June 12 in The BMJ.
Kaijie Yang, from the First Hospital of China Medical University in Shenyang, and colleagues estimated the burden, trends, and inequalities of T1DM among older adults from 1990 to 2019 in a population-based study involving adults aged ≥65 years from 21 regions and 204 countries and territories.
The researchers found that from 1990 to 2019, there was an increase in the global age standardized prevalence of T1DM among adults ≥65 years, from 400 to 514 per 100,000 population, with an average annual trend of 0.86 percent. During the same time period, mortality decreased from 4.74 to 3.54 per 100,000 population, with an average annual trend of −1.00 percent, and age-standardized disability-adjusted life-years (DALYs) decreased from 113 to 103 per 100,000 population, with an average annual trend of −0.33 percent. The most significant decrease in DALYs was seen among those aged 65 to 69, 70 to 74, and 75 to 79 years (−0.44, −0.34, and −0.42 percent per years, respectively). Compared to countries with a low-middle sociodemographic index, those with a high sociodemographic index had a 13 times faster decrease in mortality (−2.17 versus −0.16 percent per year).
"For older people with T1DM and their families worldwide, the decreasing mortality and DALYs associated with this disease is encouraging," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.